NCT06358456

Brief Summary

The goal of this clinical trial is to learn about the influence of artificial tears on measurements of healthy eyes with three different devices. The main questions it aims to answer are:

  • Do artificial tears alter the measurements of the corneal surface
  • Is there a difference between the devices used in this study This is relevant because high quality measurements improve the postoperative outcome after cataract surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
145

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

1.4 years

First QC Date

March 12, 2024

Last Update Submit

April 7, 2024

Conditions

Keywords

artificial tearskeratometrytopography

Outcome Measures

Primary Outcomes (1)

  • Does the application of artificial tears (Artelac EDO) alter the measurement of the anterior surface of the cornea (K mean in Diopters) using devices that either use keratometry or Scheimpflug-technology (IOL Master 700, Pentacam AXL or Galilei G6)

    Difference of measurement of the mean corneal refractive power in diopters before artificial tear application and after artificial tear application using one of three devices (IOL Master 700, Pentacam AXL or Galilei G6)

    Comparison between the baseline measurements and the measurements 30 seconds after artificial tear application

Secondary Outcomes (3)

  • Is there any difference in anterior corneal refractive power measurements (K mean in Diopters) between the three different devices (IOL Master 700, Pentacam AXL, Galilei G6) after artificial tear (Artelac EDO) application?

    Comparison between the baseline measurements and the measurements 30 seconds after artificial tear application

  • Does the application of artificial tears (Artelac EDO) alter the anterior astigmatism measurements (in diopters) using devices that either use keratometry or Scheimpflug-technology (IOL Master 700, Pentacam AXL or Galilei G6)

    Comparison between the baseline measurements and the measurements 30 seconds after artificial tear application

  • If there is an influence of artificial tears (Artelac EDO) on the measurement of the anterior surface of the cornea (K mean in Diopters) using the devices (IOL Master 700, Pentacam AXL or Galilei G6), how long does it last (in minutes)?

    Comparison between the baseline measurements and the measurements up to 10 minutes after artificial tear applications

Study Arms (3)

IOL Master 700

ACTIVE COMPARATOR

Patients in this arm are measured twice with the IOL master 700 without intervention. After this artificial tears are applied and followed by 4 more measurements

Drug: Artificial tearOther: No artificial tears

Pentacam AXL

ACTIVE COMPARATOR

Patients in this arm are measured twice with the Pentacam AXL without intervention. After this artificial tears are applied and followed by 4 more measurements

Drug: Artificial tearOther: No artificial tears

Galilei G6

ACTIVE COMPARATOR

Patients in this arm are measured twice with the Galilei G6 without intervention. After this artificial tears are applied and followed by 4 more measurements

Drug: Artificial tearOther: No artificial tears

Interventions

Application of low viscosity artificial tears (Artelac EDO). The active ingredient is hypromellose (1.92 mg per 0.6 ml container).

Also known as: Artelac EDO
Galilei G6IOL Master 700Pentacam AXL

Before artificial tear application, 2 baseline measurements were taken of the cornea without any intervention

Galilei G6IOL Master 700Pentacam AXL

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy eyes

You may not qualify if:

  • Any prior intraocular surgery or trauma
  • Any corneal pathology (ABMD, Fuch's, etc.)
  • Active ocular pathology (e.g., amblyopia, ARMD)
  • Contact lens wear within 2 weeks of study
  • Any corneal relaxing incisions or astigmatic keratotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goethe University Hospital

Frankfurt am Main, Hesse, 60590, Germany

Location

Related Publications (1)

  • Roggla V, Leydolt C, Schartmuller D, Schwarzenbacher L, Meyer E, Abela-Formanek C, Menapace R. Influence of Artificial Tears on Keratometric Measurements in Cataract Patients. Am J Ophthalmol. 2021 Jan;221:1-8. doi: 10.1016/j.ajo.2020.08.024. Epub 2020 Aug 21.

    PMID: 32828877BACKGROUND

MeSH Terms

Interventions

Lubricant Eye Drops

Intervention Hierarchy (Ancestors)

Ophthalmic SolutionsPharmaceutical SolutionsSolutionsPharmaceutical PreparationsTherapeutic UsesPharmacologic ActionsChemical Actions and UsesLubricantsSpecialty Uses of Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The investigator and patient knew which device they were tested on
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: one arm for each diagnostic device (three in total)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Thomas Kohnen

Study Record Dates

First Submitted

March 12, 2024

First Posted

April 10, 2024

Study Start

November 20, 2020

Primary Completion

April 22, 2022

Study Completion

April 22, 2022

Last Updated

April 10, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations